PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2018.3162019512706-717The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer SubtypesXingen Wang, Julia Y. S. Tsang, Michelle A Lee, Yun-Bi Ni, Joanna H Tong, Siu-Ki Chan, Sai-Yin Cheung, Ka Fai To, Gary M Tsehttp://e-crt.org/upload/pdf/crt-2018-316.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2018.316, http://www.e-crt.org/upload/pdf/crt-2018-316.pdf
Clinical Breast Cancer10.1016/j.clbc.2022.04.0012022Identification of Breast Cancer Subtypes Based on Gene Expression Profiles in Breast Cancer StromaMd. Nazim Uddin, Xiaosheng Wanghttps://api.elsevier.com/content/article/PII:S1526820922000702?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820922000702?httpAccept=text/plain
Breast Diseases: A Year Book Quarterly10.1016/j.breastdis.2012.01.043201223145-47Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: A retrospective clinical studyC.R. Correahttps://api.elsevier.com/content/article/PII:S1043321X12000458?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1043321X12000458?httpAccept=text/plain
Clinical Breast Cancer10.1016/j.clbc.2017.02.0052017173e165Molecular Subtypes and Lower Inner Quadrant Tumors in Breast Cancer: Debate Is Still OngoingKadri Altundaghttps://api.elsevier.com/content/article/PII:S1526820917300198?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820917300198?httpAccept=text/plain
Clinical Breast Cancer10.3816/cbc.2005.s.00720056S4Introduction Clinical Value of Fulvestrant in Breast CancerWilliam J. Gradisharhttps://api.elsevier.com/content/article/PII:S1526820911704785?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820911704785?httpAccept=text/plain
Breast Cancer: Basic and Clinical Research10.4137/bcbcr.s1372720148BCBCR.S13727Oncotype Dx Results in Multiple Primary Breast CancersMichael J. Toole, Kelley M. Kidwell, Catherine Van Poznakhttp://journals.sagepub.com/doi/pdf/10.4137/BCBCR.S13727, http://journals.sagepub.com/doi/full-xml/10.4137/BCBCR.S13727, http://journals.sagepub.com/doi/pdf/10.4137/BCBCR.S13727
Breast Cancer Research and Treatment10.1007/s10549-011-1489-z20111302421-423Struggling with subtypes: trying to bridge the gap between molecular breast cancer subtypes and clinical managementNadia Harbeckhttp://link.springer.com/content/pdf/10.1007/s10549-011-1489-z.pdf, http://link.springer.com/article/10.1007/s10549-011-1489-z/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10549-011-1489-z
Clinical Breast Cancer10.3816/cbc.2002.s.00220023S8-S11Overview: Gemcitabine as Single-Agent Therapy for Advanced Breast CancersDebu Tripathyhttps://api.elsevier.com/content/article/PII:S1526820911702798?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820911702798?httpAccept=text/plain
Clinical Breast Cancer10.1016/j.clbc.2022.04.0052022Relationship Between Breast Density, Breast Cancer Subtypes, and PrognosisDaisuke Yamada, Sachiko Ohde, Yuka Kajiura, Kazuyo Yagishita, Fumi Nozaki, Koyu Suzuki, Naoki Kanomata, Hideko Yamauchi, Hiroko Tsunodahttps://api.elsevier.com/content/article/PII:S152682092200074X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S152682092200074X?httpAccept=text/plain
The Breast10.1016/j.breast.2018.08.058201841S20Prognostic value of breast cancer subtypes based on ER/PR, HER2 expression and ki-67 index in women received adjuvant therapy after conservative surgery for early stages breast cancer a retrospective clinical studyMennaAllah Foudahttps://api.elsevier.com/content/article/PII:S0960977618302017?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0960977618302017?httpAccept=text/plain